|
End-of-day quote
Dhaka S.E.
27/10/2026
|
5-day change | 1st Jan Change | ||
| 77.50 BDT | +0.52% |
|
+0.13% | +9.31% |
| Market Cap | 17.44B 141M 126M 117M 106M 198M 13.37B 200M 1.4B 555M 7.01B 528M 517M 22.22B | P/E 2024 |
5.9x | P/E 2025 | 6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 40.31B 325M 292M 270M 245M 457M 30.91B 463M 3.23B 1.28B 16.2B 1.22B 1.2B 51.37B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 1.06x |
| Free-Float |
51.84% | Yield 2024 |
5.11% | Yield 2025 | 4.85% |
| 1 day | +0.52% | ||
| 1 week | +0.13% | ||
| Current month | -0.90% | ||
| 1 month | -1.90% | ||
| 3 months | -6.17% | ||
| 6 months | +2.65% | ||
| Current year | +9.31% |
| 1 week | 76.5 | 78.4 | |
| 1 month | 76.2 | 78.8 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 111 | |
| 10 years | 54.2 | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 30/09/1995 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 17/03/1975 | |
| Director/Board Member | 76 | 14/04/1981 | |
| Chairman | 69 | 04/09/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.52% | +0.13% | +2.92% | -8.82% | 132M | ||
| +0.22% | -0.14% | +55.12% | +128.82% | 1,143B | ||
| +0.91% | +3.61% | +41.21% | +84.57% | 647B | ||
| -0.12% | -0.93% | +25.59% | +106.14% | 506B | ||
| +0.63% | +2.33% | +49.21% | +67.82% | 384B | ||
| +0.86% | -4.37% | +61.16% | +37.93% | 350B | ||
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | ||
| -0.25% | +1.62% | +2.20% | +26.65% | 265B | ||
| +0.75% | +2.05% | +53.85% | +71.25% | 242B | ||
| +0.25% | +1.64% | +32.05% | +107.62% | 197B | ||
| Average | +0.48% | +0.76% | +34.82% | +67.57% | 402.77B | |
| Weighted average by Cap. | +0.44% | +0.71% | +42.24% | +88.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 31.93B 258M 231M 214M 194M 362M 24.48B 366M 2.56B 1.02B 12.83B 968M 947M 40.7B | 35.94B 290M 260M 240M 218M 407M 27.55B 412M 2.88B 1.14B 14.44B 1.09B 1.07B 45.8B |
| Net income | 2.46B 19.83M 17.79M 16.43M 14.9M 27.85M 1.88B 28.19M 197M 78.24M 987M 74.42M 72.83M 3.13B | 2.43B 19.6M 17.6M 16.25M 14.73M 27.54M 1.86B 27.87M 195M 77.36M 976M 73.59M 72.02M 3.1B |
| Net Debt | 22.18B 179M 161M 148M 135M 251M 17.01B 255M 1.78B 706M 8.91B 672M 658M 28.27B | 22.87B 185M 166M 153M 139M 259M 17.54B 263M 1.83B 729M 9.19B 693M 678M 29.15B |
Employees
9,025
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/10/26 | BDT 77.50 | +0.52% | 233,599 |
| 26/10/26 | BDT 77.10 | +0.26% | 80,142 |
| 25/10/26 | BDT 76.90 | -0.65% | 148,480 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















